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Summary: The absolute and relative concentrations of 16 plasma amino acids in 48 mostly dystrophic infants
and children (median of age 11A years) with extrahepatic biliary atresia and mainly stable preterminal cirrhosis
were compared with those of controls. Patient plasma amino acid data were analysed statistically for diagnostic
usefulness and correlated with standard biochemical quantities of liver function and of liver perfusion. In the
patients the total amounts of non-essential and essential amino acids were reduced by 19%, and with the
same significance (p < 0.0005). Plasma tyrosine was increased (+40%), while taurine (—44%) and branched
chain amino acids (+28.8% to —34.7%) were decreased. Methionine values varied widely. In the molar
fractional plasma amino acid profile, only alanine, valine, and leucine were decreased, while threonine,
methionine, tyrosine, phenylalanine, ornithine, and serine were increased. Discriminate function analysis
showed that the plasma amino acid data discriminated 93.8% of the patients from controls. The concentrations
of some amino acids in plasma seemed to have been influenced by protein-calorie deficiency in the patients.
The valine/tyrosine ratio and the Fischer index (ratio branched chain/aromatic amino acids) were significantly
reduced in the patients versus controls (1.54 + 0.55 vs 3.08 + 0.55 and 1.66 + 0.39 vs 3.00 + 0.48). A number
of significant correlations (range of r: 0.37 — 0.59, p < 0.05, 30—48 data pairs) were calculated between
plasma amino acid data and several standard biochemical quantities of liver function. The statistical analyses
also showed that the Fischer index began to decrease gradually and linearly early in the progression of liver
failure. It is concluded that plasma amino acid data can be useful in the evaluation of the progression of liver
failure and possibly of the nutritional status in liver transplant candidates with biliary atresia.
Introduction donor liver and low body weight in recipients are
Extrahepatic biliary atresia is a congenital structural seriof probl*™> f that ,f^ and ̂ imal ̂
defect of the hepatic biliary tree. Its frequency is tional care of the chronically malnourished transplan-
estimated to be 1: 8000 to 1 :15000. It is responsible 'at'On can*dates are vital (13). Single laboratory
for 75 to 80% of the cases of conjugated hyperbili- fmdmgs, ™U "™?* not be indlcatlve °f. "*Pend'ng
rubinaemia in children (1, 2). In the natural course ^mmal llver failure m ext^epatic biliary atresia
of extrahepatic biliary atresia, 70 to 90% of cases die ^ '"
within 2-3 years (3). Affected patients may benefit, In adult cirrhotics, plasma concentrations of the ar-
for a time, from hepatoportoenterostomy (4), but omatic amino acids are increased and those of
most eventually develop biliary cirrhosis and pro- branched chain amino acids are decreased. Methio-
gressive liver failure (5, 6). The only definitive therapy nine can be markedly elevated (7-9). The Fischer
appears to be liver transplantation (3, 6). Lack of index (the ratio of the sum of the concentrations of
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the branched chain amino acids to that of phenylal-
anine plus tyrosine) is subnormal and may be corre-
lated with liver histology (10, 11) and with hepatic
synthetic capacity (9). One publication (12) has dealt
with this subject in children with extrahepatic biliary
atresia and cirrhosis. In these 26 patients, 6 of whom
suffered from terminal hepatic failure, total free
plasma amino acids were significantly elevated; raised
plasma methionine showed the greatest deviation
from normal, and their plasma taurine was signifi-
cantly decreased. The Fischer index was depressed, as
in adults.
We present a retrospective analysis of data on 16
plasma amino acids in infants and children with ex-
trahepatic biliary atresia and preterminal cirrhosis.
The aims of the study were to detect early possibly
treatable amino acid imbalances or deficiencies and
to probe the usefulness of plasma amino acid data in
the diagnosis and monitoring of progression of liver
failure in extrahepatic biliary atresia liver transplan-
tation candidates.
Patients and Methods
All 48 children (27 females, 21 males) had been evaluated during
the time period 1983 to 1988 at our hospital, as liver trans-
plantation candidates. Extrahepatic biliary atresia had been
confirmed by intraoperative cholangiogram and by liver biopsy.
Seven patients also had intrahepatic biliary hypoplasia. Cirrho-
sis had developed in 44 patients, despite previous hepatopor-
toenterostomy, and in 4 others without such surgery. The me-
dian age was lYi2 years (5 months to 7'/ia years) and the median
of postoperative time in respective patients was 11 months (2
months to 72/i2 years) at the time of the plasma amino acid
analyses. The median of body weight on standard growth curves
(13) was at the 5th percentile (range 3rd-97th percentile) for
age. Higher body weight in some cases was due to ascites. All
patients were on age-adequate oral nutrition (1.5 to 2 g of
protein/kg · d) and supplemental medium chain triacylglycerols.
The medicinal treatment consisted of (No./total): diuretics
23/48; vitamins A, D, E 31/48; vitamin K 25/48; phenobarbital
17/48; cholestyramin 16/48; pancreas enzymes 11/48; antibiotics
17/48; antacids 6/48.
Evaluation of liver function
Table 1 summarises the evaluation of liver function by standard
laboratory quantities. Total protein, albumin, prothrombin time
(Quick), partial thromboplastin time, total bilirubin, cholin-
esterase activity, as well as activities of the serum liver enzymes:
aspartate aminotransferase, alanine aminotransferase, gluta-
mate dehydrogenase, alkaline phosphatase und y^glutamyl-
transferase, were determined by standard methods. Lipoprotein
X and total serum bile acids were determined according to
Talafant & Tovarek (14), with the Merck (Darmstadt, Germany)
enzymatic-colorimetric kit according to the instructions of the
manufacturer.
Extrahepatic blood flow was determined from the clearance
rate of an i. v. bolus of "Tc-labelled human serum albumin.
The rate constant "k" for the monoexponential equation, which
describes the clearance rate of an i.v. bolus of "Tc-labelled
human serum albumin, is directly proportional to estimated
hepatic blood flow (15, 16) and is referred to hereafter as
estimated hepatic blood flow(k). The portal venous fraction of
total hepatic perfusion was measured as described after an i. v.
bolus of "Tc-labelled diethylenetriamine-pentaacetic acid (16).
The 48 patients had been scored as follows, according to a
standardised prognostic risk score (3), representing increasing
priority for liver transplantation: 0: 16 (33.3%); 1: 16 (33.3%);
2: 10 (20.8%); 3: 6 (12.5%).
Tab. 1. Clinical chemical and scintigraphic data on hepatic synthetic function, hyperammonaemia, hepatocellular necrosis,
cholestasis, estimated hepatic blood flow and portal venous fraction of liver perfusion in the children with biliary atresia
and liver cirrhosis, compared with laboratory reference ranges.
Patient values N Reference range
Albumin (g/l)










Total serum bile acids (μιηοΐ/l)
Estimated hepatic blood flow(k) (min"1)












































































^ 25 patients were receiving supplemental vitamin K
* P1!™^ i?6 i?eiri°d °f Study the substrate used to measure cholinesterase activity was changed from acetylthiocholine to
butyrylthiochohne. Therefore, for comparability, the patient values are expressed as percent of the respective lower normal
value, 1900 U/l or 3.5 kU/1, respectively.
3 Upper limits of normal.
N = number of patients investigated
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Amino acid analysis
A laboratory reference of 27 healthy age-matched children
(13 ?, 14 (J; median age !9/iz years) served as a control collective.
Heparinised venous blood samples were collected after an over-
night fast. When amino acid analysis was not immediately
possible, blood plasma was kept frozen at —20QC or below.
Plasma was deproteinised by addition of an equal volume of
aqueous 50 g/1 sulphosalicylic acid, then centrifuged. An aliquot
of the supernatant was diluted with an equal volume of lithium
citrate loading buffer. The analyses were carried out with the
Biotronik (Munich, Germany) models LC 6000 and LC 2000
according to the manufacturer's instructions. The day to day
coefficients of variation for individual amino acids in a reference
plasma sample ranged between 3 and 6%.
Twenty nine (60.4%) of the amino acid determinations were
performed on the same blood samples taken for clinical chem-
ical determinations. Seven (14.6%) were performed on samples
collected within the same 24 h and 9 (18.8%) others were
performed on samples taken within the same 48 h as the samples
for clinical chemistry. In the case of 3 (6.3%) samples this time
difference exceeded 8 days. Because some samples were stored
up to 1 month prior to analysis, and because many samples
had not been immediately deproteinised, glutamine, glutamic
acid, cystine and tryptophan were not evaluated. Citrulline
values were not available in the greater proportion of controls,
and they were therefore excluded. Taurine was excluded from
total free plasma amino acids and from the molar fraction
analysis, as plasma values were available for only 17 of the
extrahepatic biliary atresia patients.
We compared the mean concentrations of 16 individual plasma
amino acids; total free plasma amino acids; and the mean molar
fractions of individual amino acids (individual molar concen-
trations of amino acids over molar total of amino acids). We
also examined the data for those amino acids which best dis-
criminated patients from controls. Total free plasma amino
acids was correlated with body weight percentiles. All individual
amino acid data, the Val/Tyr ratio and the branched chain
amino acids/aromatic amino acids ratio (Fischer index) were
correlated with standard biochemical quantities of residual he-
patic function (tab. 1), in the patients as a group, and in
subgroups of patients at different stages of liver failure.
Statistical analysis
Mean values and standard deviation were used for normally
distributed data. Differences between mean values of data sets
.were anlaysed for significance by t-test with the p value set at
less than 0.05. Discriminate function analysis was used to de-
termine those amino acids which were chiefly responsible for
the differences between the patient versus the control group.
Interdependence between pairs of data sets was analysed via
linear regression analysis and the Pearson coefficient of corre-
lation. Linear correlations between mutually dependent varia-
bles was expressed as the correlation coefficient "r". The SPSS
software (SPSS Inc., Gorinchen, The Netherlands) licenced at
the Medizinische Hochschule Hannover (SPSS-X, Schub 1984)
was used for all statistical analyses.
Tab. 2. Comparison of concentrations of 16 individual amino acids and total concentration of free amino acids, free essential
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1 Includes isoleucine, leucine, lysine, methionine, phenylalanine, threonine, and valine. Tryptophan was not determined.
2 Includes alanine, arginine, glycine, histidine, ornithine, proline, serine and tyrosine. Citrulline was omitted.
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Results
The concentrations of 16 plasma amino acids in pa-
tients and controls are listed in table 2 and a graphical
summary is presented in figure 1. In the extrahepatic
biliary atresia patients, total free plasma amino acids
(tab. 2) was significantly lower than in controls by
about 19%. Essential and non-essential amino acids
were lower by almost the same amount. The mean
concentration of plasma taurine in 17 extrahepatic
biliary atresia patients was only about 44%
(p < 0.0005) of the control value. The absolute con-
centrations of proline, glycine, alanine, valine, isoleu-
cine, leucine, lysine, histidine, and arginine showed
various degrees of reduction, which were always sig-
nificant. The absolute concentration of tyrosine was
increased on average by over 40% (p < 0.0005). In-
dividual methionine values varied widely, while the
mean concentration was in the upper range of normal
but not significantly different from the control value.
As shown in figure 1, the molar fractions of threonine,
serine, methionine, tyrosine, phenylalanine, ornithine,
but not of glycine, were significantly raised in the
extrahepatic biliary atresia group. In contrast to the
absolute plasma amino acid profile, only the contri-
butions of alanine, leucine and valine were signifi-
cantly reduced in the molar fractional plasma amino
acid profile.
Plasma valine correlated strongly with leucine in both
controls (r = 0.64, p < 0.0005) and patients
(r = 0.69, p < 0.0005). In controls, valine was cor-
related strongly with isoleucine (r = 0.73,
p < 0.0005), and isoleucine with leucine (r = 0.75,
ρ < 0.0005). In the patients, both of the latter cor-
relations were still statistically significant, but r was
smaller (r = 0.55, p < 0.0005). Other correlations be-
tween concentrations of individual amino acids were
not statistically significant.
Discriminate function analysis of amino acid data
from extrahepatic biliary atresia patients and controls
showed that valine, tyrosine, alanine, isoleucine, and
histidine, in that order, were chiefly responsible for
quantitative differences in the plasma amino acid pro-
file in extrahepatic biliary atresia patients versus con-
trols. When these 5 amino acids were used simulta-
neously as multivariant discriminators on the com-
mon data pool, it was possible to assign 45 (93.8%)
of the 48 extrahepatic biliary atresia patients and 26
(96.3%) of the controls correctly to their group of
origin. The mean value of the Fischer index (3.00 ±
0.48 vs. 1.66 ± 0.39) (fig. 2) and the valine/tyrosine
ratio (3.08 ± 0.55 vs 1.54 ± 0.55) were significantly
depressed in the extrahepatic biliary atresia group.
Both ratios were equally as effective as the 5 amino
acids listed above in. discriminating extrahepatic bili-



























































































Taurine Thr Ser Pro Gly Ala Val Met He Leu Tyr Phe Om Lys His Arg
Fig. 1. Absolute (open bars) and relative (hatched bars) fasting plasma concentrations of 16 amino acids in children with
extrahepatic biliary atresia and cirrhosis.
Given are mean and SEM of the fractions of the mean control values. Taurine was not included in the molar fraction
aminogram (see materials and methods).
χ: ρ < 0.0005 A: p < 0.05 o: not measured
Δ: ρ < 0.005 Θ: not significant
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Fig. 2. Comparison of the Fischer index in controls with pa-
tients with biliary atresia.
Given are means ± SEM. The mean numerical value
of the Fischer index was very similar to that of the mean
valine/tyrosine ratio:
Controls N Biliary atresia
patients
N
Fischer x: 27 x: 48
index 3.003 ± 0.476 1.656 ± 0.394
Valine/ x: 27 x: 48
tyrosine 3.082 ± 0.554 1.540 ± 0.548
1, 2, 3) shows division of patients into 3 groups accord-
ing to decreasing intervals of the Fischer index; see fig. 3
and text in Results section.
* Denotes those two patients excluded from the statis-
tical calculations presented in fig. 3.
Certain amino acid data (tab. 3) showed a significant
degree of linear correlation, especially with quantities
of hepatic synthetic capacity, with cholestasis and with
estimated hepatic blood flow(k). Methionine showed
a weak negative correlation with plasma albumin and
a negative correlation with estimated hepatic blood
flow(k). Leucine was correlated positively only with
plasma albumin, and isoleucine was correlated nega-
tively only with cholinesterase. Phenylalanine corre-
lated negatively with cholinesterase and with Quick
values. Tyrosine correlated negative with Quick values
and with plasma albumin, and positively with partial
thromboplastin time. Tyrosine correlated negatively
with estimated hepatic blood flow(k) and with the
cholestasis marker lipoprotein-X. The Fischer index
and the valine/tyrosine quotient both correlated di-
rectly with cholinesterase, Quick value, plasma albu-
min, estimated hepatic blood flow(k) and with lipo-
protein-X, and inversely with partial thromboplastin
time. Valine (not included in tab. 3) was the only
amino acid which correlated positively with the portal
venous fraction of liver perfusion (r = 0.33,
p < 0.05).
To investigate further the linear relationships between
the Fischer index and some standard laboratory tests,
the children with extrahepatic biliary atresia were
arbitrarily divided into three groups (fig. 2) approxi-
mately according to decreasing 1-SD-decrements from
the maximal value of the Fischer index (fig. 2). The
group mean values for conventional quantities (tab.
1) of liver function were then analysed for significant
differences. It can be seen in figure 3 that decreases
in the value of the Fischer index were paralleled by
linear changes in the values for plasma albumin, Quick
value, estimated hepatic blood flow(k) and in partial
thromboplastin time. The differences in the mean
values for albumin and estimated hepatic blood
flow(k) in groups 1 and 2 were not statistically sig-
nificant. Total free plasma amino acids did not cor-
relate with body weight percentiles. No individual
patient plasma amino acid data in extrahepatic biliary
atresia correlated significantly with any of the follow-
ing quantities: weight percentiles; plasma ammonia;
activity of transaminases; bilirubin concentrations;
alkaline phosphatase; total serum bile acids or total
risk score (data not shown).
Discussion
The risk scores (3) of our patients were such that
none were top priority liver transplantation candi-
dates. Their total free plasma amino acids should
therefore have been subject to a relatively small influ-
ence by liver cell necrosis (11, 17). They differed in
this important respect from the children studied by
Weisdorf et al. (12). Our patients also had a higher
plasma albumin concentration and a better coagula-
tion status than those in that study. To our knowledge
this is the first study which compares liver perfusion
data with amino acid data in children with extrahe-"
patic biliary atresia and cirrhosis.
The absolute and the fractional plasma amino acid
profile in our patients were unbalanced, as described
in adult cirrhotics (7-9). Tyrosine was highly in-
creased; there was a trend to higher absolute phen-
ylalanine and methionine values, and branched chain
amino acids were decreased. The molar fractional
plasma amino acid profile in our group also revealed
significant increases in the proportions of tyrosine,
phenylalanine and methionine, and reductions in
those of branched chain amino acids.
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Tab. 3. Significant statistical correlations between plasma concentrations of individual amino acids, or ratios derived from plasma














































Quick Partial Lipoprotein-X Estimated hepatic
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Ν = Number of data pairs
For estimated hepatic blood flow(k) see Materials and Methods; Fischer index: Branched chain amino acids (sum of molar plasma
concentrations) over aromatic amino acids, tyrosine, phenylalanine (sum of molar plasma concentrations)
In our group, total free plasma amino acids was
subnormal, and both essential and non-essential
amino acids were equally affected. Weisdorf et al. (12)
reported total free plasma amino acids as increased.
Like these authors, we found a significant decrease
of plasma taurine, which was raised in adult patients
(18). Further aberrations were seen in the absolute
concentrations of proline, glycine, alanine, lysine and
arginine, and in the relative concentrations of threo-
nine, serine and ornithine.
The plasma amino acid profile in cirrhosis is com-
plexly related to the extent of protein-calorie defi-
ciency, residual liver function, liver perfusion, im-
paired hormone function, and vitamin status (19, 20,
21). While the plasma amino acid profile in our pa-
tients was not totally typical for protein-calorie mal-
nutrition (21, 22), their general hypoaminoacidaemia
and deficiency of important substrates of ghicogene-
sis, especially alanine (23, 24), are seen as signs of

































Fig. 3. Comparison of mean values of standard laboratory tests in patients after arbitrary separation into 3 groups according to
1 bD decrements in the Fischer index value. n &
Depicted are mean values and standard error of the mean. Units are as in table 1
1) Group 1, Fischer index: 2.274 - 1.865 (n = 12). a) 1 vs 2« ρ < 0 05 I
2) Group 2, Fischer index: 1.864 - 1.455 (n = 22). b) 2 vs 3« ρ < 005
' FlSCher indCX: *'454 " L°45 (n " 14)· c) 1 vs 3i ρ < θ'.05rate constant of elimination proportional to estimated hepatic blood flow.
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due to hypermetabolism and poor nutrient absorption
(26, 27). We have no evidence that their taurine deficit
resulted from dietary amino acid deficiencies as sug-
gested by others (12). Increased formation of taurine-
conjugated bile acids (28) may have reduced their
taurine reserves.
Hyperammonaemia in our patients was not correlated
with plasma concentrations of branched chain amino
acids or with Fischer index values (29, 30, 31). Lack
of correlation of plasma branched chain amino acids
with estimated hepatic blood flow(k) and the presence
of normoglycaemia also speak against inadequate
degradation of insulin (19, 29, 32) as the reason for
their low plasma branched chain amino acids. In our
patients, leucine, which is ketogenic, showed an ab-
normally high correlation with valine, which is glu-
coneogenic. Compared with controls, the normally
strong correlation of valine with isoleucine was
weaker. In calorie deprivation branched chain amino
acids may become a source of fuel for muscle (19, 33,
34). We postulate that in our extrahepatic biliary
atresia children the branched chain amino acids deficit
resulted from their use as alternative energy sub-
strates, and that the low concentrations of these
amino acids may indicate increased dietary require-
ments for them (35).
In our probands, plasma tyrosine correlated inversely
with estimated hepatic blood flow(k), indicating that
reduced hepatic extraction of systemic tyrosine (36,
37) may be a cause of hypertyrosinaemia in cirrhosis
due to extrahepatic biliary atresia. Reduced intracel-
lular activity of hepatic tyrosine amino transaminase
in cirrhotics has not been confirmed (38, 39).
In our hands, the discriminate function analysis of a
combination of five plasma amino acids provided a
highly accurate segregation of individual extrahepatic
biliary atresia patients at early stages of cirrhotic
alteration from controls. The mean value and the
standard deviation of the Fischer index in our control
collective were very similar to published values for
adult controls (8, 9, 10) and healthy children (12).
Decreases in the Val/Tyr ratio and in the Fischer index
were measurable in our patients before hepatic failure
had become critical. In our study, both ratios discrim-
inated patients from controls as effectively as the
combination of 5 amino acids listed above. Several
of the amino acid data correlated well with certain
conventional quantities of hepatic function, especially
with synthetic capacity. The analysis of variance of
the mean values of standard quantities in the three
groups of children with extrahepatic biliary atresia
showed that the Fischer index decreased linearly with
decreasing liver synthetic function, as in adults (9,
10). Two of the quantities, cholinesterase and Quick
value of the prognostic risk score (3) used in our
hospital, correlated significantly with amino acid
data, whereas the total risk score did not.
Concerning the prognostic value of the Fischer index,
only 18 of our 48 patients could be followed up for
a period of 2 years. In 9 of these, the Fischer index
value was greater than 1.5. Of these, 1 died within 6
months, 1 within 18 months, but the remaining 7
survived for up to 24 months after the initial inves-
tigation. On the other hand, in the group of 9 patients
with values less than 1.5, three had died within 6
months, 6 others within 18 months, and only 1 was
alive 24 months later.
We therefore conclude that in children with extrahe-
patic biliary atresia and cirrhosis, the valine/tyrosine
ratio and the Fischer index are good indicators of
hepatic synthetic capacity, that plasma tyrosine con-
centration correlates with estimated hepatic blood
flow and with cholestasis, and that these indicators
and the plasma amino acid profile should be used in
the biochemical and nutritional (35, 40) evaluation of
patients awaiting liver transplantation.
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